Barkın Berk

569 total citations
49 papers, 493 citations indexed

About

Barkın Berk is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Barkın Berk has authored 49 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 17 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Barkın Berk's work include Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Cancer therapeutics and mechanisms (6 papers). Barkın Berk is often cited by papers focused on Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Cancer therapeutics and mechanisms (6 papers). Barkın Berk collaborates with scholars based in Türkiye, United States and United Kingdom. Barkın Berk's co-authors include Stefano Costanzi, Şeref Demirayak, Leyla Yurttaş, Santiago Vilar, Işıl Aksan Kurnaz, Sharangdhar S. Phatak, Claudio N. Cavasotto, Giulio Ferino, Hülya Akgün and Joel Karpiak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Barkın Berk

48 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barkın Berk Türkiye 13 251 219 123 92 54 49 493
Jaime Mella Chile 18 338 1.3× 262 1.2× 144 1.2× 124 1.3× 30 0.6× 56 661
Peter Ripphausen Germany 7 125 0.5× 332 1.5× 336 2.7× 74 0.8× 11 0.2× 8 562
Anna Furimsky United States 10 82 0.3× 153 0.7× 27 0.2× 81 0.9× 34 0.6× 18 439
G.F. Ruda United Kingdom 15 131 0.5× 513 2.3× 58 0.5× 68 0.7× 113 2.1× 20 719
Matthew D. Selby United Kingdom 12 284 1.1× 215 1.0× 21 0.2× 36 0.4× 23 0.4× 22 492
Giampiero Colombano Italy 9 101 0.4× 210 1.0× 32 0.3× 105 1.1× 22 0.4× 11 447
Aloysius T. Nchinda South Africa 13 223 0.9× 256 1.2× 104 0.8× 58 0.6× 25 0.5× 27 557
Douglas C. Beshore United States 16 451 1.8× 391 1.8× 52 0.4× 114 1.2× 90 1.7× 29 750
Peter G. Nell Germany 11 287 1.1× 213 1.0× 22 0.2× 97 1.1× 21 0.4× 14 544
Abdul-Quddus Kehinde Oyedele Nigeria 9 101 0.4× 200 0.9× 168 1.4× 35 0.4× 13 0.2× 14 391

Countries citing papers authored by Barkın Berk

Since Specialization
Citations

This map shows the geographic impact of Barkın Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barkın Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barkın Berk more than expected).

Fields of papers citing papers by Barkın Berk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barkın Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barkın Berk. The network helps show where Barkın Berk may publish in the future.

Co-authorship network of co-authors of Barkın Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Barkın Berk. A scholar is included among the top collaborators of Barkın Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barkın Berk. Barkın Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berk, Barkın. (2023). Acemetacin in Acute and Chronic Pain Management. Journal of Drug Delivery and Therapeutics. 13(6). 18–22. 1 indexed citations
2.
Ozansoy, Mehmet, et al.. (2022). Synthesis and in vitro antitumor activities of novel thioamide substituted piperazinyl‐1,2,4‐triazines. Journal of Heterocyclic Chemistry. 59(8). 1333–1340. 7 indexed citations
3.
Yurttaş, Leyla, et al.. (2022). Novel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors. Journal of Molecular Structure. 1264. 133193–133193. 5 indexed citations
4.
Berk, Barkın, et al.. (2022). Investigation of hidden crisis of prescription drug abuse in turkey: pregabalin monitoring. 60(4). 313–313. 1 indexed citations
5.
Berk, Barkın, et al.. (2022). Synthesis, antimicrobial activity and modeling studies of thiazoles bearing pyridyl and triazolyl scaffolds. Zeitschrift für Naturforschung C. 77(9-10). 429–446. 4 indexed citations
6.
Si̇pahi̇, Hande, et al.. (2021). Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation. Zeitschrift für Naturforschung C. 77(7-8). 279–285. 1 indexed citations
7.
Yurttaş, Leyla, et al.. (2020). Design and synthesis of new donepezil analogs derived from arylpiperazine scaffold as acetylcholinesterase inhibitors. Phosphorus, sulfur, and silicon and the related elements. 196(3). 283–293. 8 indexed citations
8.
Yurttaş, Leyla, Barkın Berk, Hande Si̇pahi̇, et al.. (2020). Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition. European Journal of Medicinal Chemistry. 212. 113125–113125. 16 indexed citations
9.
Ayla, Şule, Nil Molinas Mandel, Metin Özkan, et al.. (2020). Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Journal of Oncology. 2020. 1–7. 4 indexed citations
10.
Demirayak, Şeref, et al.. (2019). Novel thiazole‐piperazine derivatives as potential cholinesterase inhibitors. Journal of Heterocyclic Chemistry. 56(12). 3370–3386. 18 indexed citations
11.
Berk, Barkın, et al.. (2018). Thiazole‐substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors. Drug Development Research. 79(8). 406–425. 26 indexed citations
13.
Berk, Barkın, et al.. (2018). Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives. Bioorganic & Medicinal Chemistry. 26(8). 1986–1995. 31 indexed citations
14.
Akgün, Hülya, et al.. (2012). Synthesis and antimycobacterial activity of some phthalimide derivatives. Bioorganic & Medicinal Chemistry. 20(13). 4149–4154. 53 indexed citations
15.
Vilar, Santiago, Joel Karpiak, Barkın Berk, & Stefano Costanzi. (2011). In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. Journal of Molecular Graphics and Modelling. 29(6). 809–817. 42 indexed citations
16.
Vilar, Santiago, Giulio Ferino, Sharangdhar S. Phatak, et al.. (2010). Docking-based virtual screening for ligands of G protein-coupled receptors: Not only crystal structures but also in silico models. Journal of Molecular Graphics and Modelling. 29(5). 614–623. 69 indexed citations
17.
Maruoka, Hiroshi, Matthew O. Barrett, Hyojin Ko, et al.. (2010). Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications. Journal of Medicinal Chemistry. 53(11). 4488–4501. 34 indexed citations
18.
Akgün, Hülya, et al.. (2009). Nitric Oxide Releasing Derivatives of [(2-Chloroethyl)ureido] Benzoic Acid Esters as Potential Antineoplastic Agents. TURKISH JOURNAL OF CHEMISTRY. 3 indexed citations
19.
Berk, Barkın, Hülya Akgün, Kevser Erol, et al.. (2005). New 8-substituted xanthiene derivatives as potent bronchodilators. Il Farmaco. 60(11-12). 974–980. 18 indexed citations
20.
Balkan, Ayla & Barkın Berk. (2003). Novel Approaches to Anti-Inflammatory Agents as Therapeutics for Asthma. 2(1). 9–18. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026